Artificial narrow intelligence models, trained for specific intended purposes, have gained approval and recommendation for cancer treatment. Generalist medicial artificial intelligence (GMAI) models are now being developed for cancer treatment. Policy makers have a stark choice: radically adapt frameworks, block generalist approaches or force them onto narrower tracks.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Moor, M. et al. Foundation models for generalist medical artificial intelligence. Nature 616, 259–265 (2023).
Tu, T. et al. Towards generalist biomedical AI. NEJM AI 1, AIoa2300138 (2024).
Liang, M., Li, Z., Chen, T. & Zeng, J. Integrative data analysis of multi-platform cancer data with a multimodal deep learning approach. IEEE/ACM Trans. Comput. Biol. Bioinform. 12, 928–937 (2015).
Bubeck, S. et al. Sparks of artificial general intelligence: early experiments with GPT-4. Preprint at https://doi.org/10.48550/arXiv.2303.12712 (2023).
Gilbert, S., Harvey, H., Melvin, T., Vollebregt, E. & Wicks, P. Large language model AI chatbots require approval as medical devices. Nat. Med. 29, 2396–2398 (2023).
Singhal, K. et al. Large language models encode clinical knowledge. Nature 620, 172–180 (2023).
FDA. Use of public human genetic variant databases to support clinical validity for genetic and genomic-based in vitro diagnostics. https://www.fda.gov/media/99200/download (2018).
Boehm, K. M., Khosravi, P., Vanguri, R., Gao, J. & Shah, S. P. Harnessing multimodal data integration to advance precision oncology. Nat. Rev. Cancer 22, 114–126 (2022).
Cohen, I. G. et al. How AI can learn from the law: putting humans in the loop only on appeal. npj Digit. Med. 6, 1–4 (2023).
Morrell, W., Shachar, C. & Weiss, A. P. The oversight of autonomous artificial intelligence: lessons from nurse practitioners as physician extenders. J. Law Biosci. 9, lsac021 (2022).
Balagopalan, A. et al. The road to explainability is paved with bias: measuring the fairness of explanations. In 2022 ACM Conference on Fairness, Accountability, and Transparency 1194–1206 (ACM, 2022).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
S.G. has or has had consulting relationships with Una Health GmbH, Lindus Health Ltd, Flo Ltd, Thymia Ltd, FORUM Institut für Management GmbH, High-Tech Gründerfonds Management GmbH and Ada Health GmbH; and he holds share options in Ada Health GmbH. J.N.K. provides consulting services for Owkin, France; DoMore Diagnostics, Norway and Panakeia, UK, he holds shares in StratifAI GmbH and he has received honoraria for lectures by Bayer, Eisai, MSD, BMS, Roche, Pfizer and Fresenius.
Peer review
Peer review information
Nature Reviews Cancer thanks Olivier Elemento and the other anonymous reviewers for their contribution to the peer review of this work.
Rights and permissions
About this article
Cite this article
Gilbert, S., Kather, J.N. Guardrails for the use of generalist AI in cancer care. Nat Rev Cancer 24, 357–358 (2024). https://doi.org/10.1038/s41568-024-00685-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41568-024-00685-8